Prospects and Challenges of Induced Pluripotent Stem Cells in Equine Health.
Authors: Donadeu F Xavier, Esteves Cristina L
Journal: Frontiers in veterinary science
Summary
# Editorial Summary: Induced Pluripotent Stem Cells in Equine Medicine Induced pluripotent stem cells (iPSCs)—adult cells reprogrammed to an embryonic-like state capable of differentiating into any tissue type—represent a transformative avenue for equine regenerative medicine, particularly given the scarcity of naturally available embryonic stem cells in horses. Donadeu and Esteves reviewed the current landscape of equine iPSC development, examining both the technological advances that have enabled successful derivation of these cells from equine tissues and the functional differentiation of iPSCs into specific cell types in vitro. Whilst human iPSC research has already progressed to clinical trials, equine applications remain in early stages; however, the species' substantial musculoskeletal injury burden and natural healing limitations position iPSC-derived therapies as exceptionally promising for conditions like tendinopathy and cartilage damage. Critical hurdles remain before clinical translation—including reproducible derivation protocols, maintaining pluripotency through extended culture, achieving reliable differentiation into therapeutically relevant cell types, and establishing robust safety profiles—yet emerging evidence suggests these technical barriers are increasingly surmountable. For practitioners managing chronic lameness and degenerative conditions, staying informed about iPSC progress is prudent, as patient-specific cellular therapies could fundamentally reshape regenerative treatment options within the next decade.
Read the full abstract on PubMed
Practical Takeaways
- •iPSC technology offers future promise for regenerating damaged tissues (tendons, cartilage, bone) from patient's own cells, potentially reducing rejection risk.
- •Clinical applications in equine practice are still several years away; current technology remains experimental and not yet ready for routine use.
- •Understanding iPSC potential helps practitioners recognize emerging regenerative options to discuss with owners, but evidence-based clinical protocols do not yet exist.
Key Findings
- •Induced pluripotent stem cells (iPSCs) can be generated from adult equine cells through transcription factor-mediated reprogramming, offering patient-specific regenerative potential.
- •Recent studies have successfully derived functional cell types from equine iPSCs for the first time, demonstrating technical feasibility.
- •Significant challenges remain in robust derivation, long-term culture, differentiation protocols, and clinical safety before equine iPSC clinical application.
- •Horses represent the species with greatest potential for iPSC applications in regenerative medicine after humans, though ESC availability remains limited.